Last reviewed · How we verify
Planned Parenthood Federation of America — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Subcutaneous depot medroxyprogesterone acetate | Subcutaneous depot medroxyprogesterone acetate | marketed | Progestin contraceptive | Progesterone receptor | Contraception |
Therapeutic area mix
- Contraception · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Pfizer · 1 shared drug class
- University of Alabama at Birmingham · 1 shared drug class
- University of Sao Paulo · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Planned Parenthood Federation of America:
- Planned Parenthood Federation of America pipeline updates — RSS
- Planned Parenthood Federation of America pipeline updates — Atom
- Planned Parenthood Federation of America pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Planned Parenthood Federation of America — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/planned-parenthood-federation-of-america. Accessed 2026-05-17.